DUO ONCOLOGY INC.

Profile

Company Names

DUO ONCOLOGY INC.

Addresses

218 OAKLAND AVE, PITTSBURGH, PA 15213

4165 BLAIR ST, PITTSBURGH, PA 15207

4165 BLAIR STREET, PITTSBURGH, PA 15207

C/O LIFEX, 2730 SIDNEY ST, STE. 300, PITTSBURGH, PA 15203

Phone Numbers

412-709-1659
412-246-8911

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$6,800,005.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-06-02 
$1,425,000.00 
$3,000,000.00 
$1,575,000.00 
Debt 
2
2023-01-31 
$4,250,005.00 
$4,250,005.00 
$0.00 
Equity 
1
2021-02-03 
$1,125,000.00 
$1,500,000.00 
$375,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ASHLEY 
DIRECTOR
VITAL THERAPIES INC   |  MALAUZAI SOFTWARE, INC.   |  DUO ONCOLOGY INC.   |  NEXTGENID, INC.
KATHERINE 
 
EICHINGER 
EXECUTIVE OFFICER
DUO ONCOLOGY INC.
JOE 
 
GATTO 
DIRECTOR
CALIFIA PHARMA, INC.   |  DUO ONCOLOGY INC.   |  ILLUDENT, INC.
JING-ZHOU 
 
HOU 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DUO ONCOLOGY INC.   |  SIRNAMED THERAPEUTICS INC.
SONG 
 
LI 
DIRECTOR, PROMOTER
FRONTIDA BIOPHARM, INC.   |  DUO ONCOLOGY INC.   |  SIRNAMED THERAPEUTICS INC.
LUSONG 
 
LUO 
DIRECTOR
RIBONAUT THERAPEUTICS, INC.   |  WINDOW THERAPEUTICS, INC.   |  DUO ONCOLOGY INC.
VICTORIA 
 
MANAX 
DIRECTOR
MANAX RUTSON HORNSILVER BIO INVESTORS LP   |  DUO ONCOLOGY INC.
STANLEY 
 
MARKS 
DIRECTOR
DUO DELIVERY LLC   |  DUO ONCOLOGY INC.   |  CYTOAGENTS, INC.   |  PREDXBIO, INC.   |  SIRNAMED THERAPEUTICS INC.
SAM 
 
ROTHSTEIN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DUO ONCOLOGY INC.
JINGJING 
 
SUN 
PROMOTER
DUO ONCOLOGY INC.
STEPHEN 
 
THORNE 
EXECUTIVE OFFICER, PROMOTER, DIRECTOR
WESTERN ONCOLYTICS LTD.   |  DUO ONCOLOGY INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2025-06-02 
2025-06-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2025-06-02 
2023-08-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-31 
2023-02-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-31 
2021-02-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2021-02-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#